Chemokine receptor binding heterocyclic compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/12 (2006.01) A61K 31/44 (2006.01) A61P 31/18 (2006.01) C07D 401/12 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2389545

The present invention is drawn to novel antiviral compounds, pharmaceutical compositions and their use. More specifically this invention is drawn to derivatives of monocyclic polyamines which have activity in standard tests against HIV- or FIV- infected cells as well as other biological activity related to binding of ligands to chemokine receptors that mediate a number of mammalian embryonic developmental processes.

L'invention concerne des composés antiviraux, des compositions pharmaceutiques et leurs utilisations. Elle concerne plus spécifiquement des dérivés de polyamines monocycliques qui possèdent une activité, dans des tests standards, contre des cellules infectées par VIH ou par FIV, aussi bien que d'autres activités biologiques se rapportant au pouvoir de liaison de ligands à des récepteurs de chemokine qui assurent une médiation dans un certain nombre de processus de développement embryonnaire de mammifères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chemokine receptor binding heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemokine receptor binding heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine receptor binding heterocyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1894097

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.